sample size for clini­cal endpoint BE study of Brinzol­amide 1% ophthal­mic [Design Issues]

posted by kishpokuri – India, 2015-11-24 15:18 (3367 d 14:41 ago) – Posting: # 15665
Views: 7,073

Hi all,
Can anyone suggest the appropriate sample size for a clinical endpoint bioequivalence study of Brinzolamide 1% ophthalmic suspension in chronic open angle glaucoma patients.
OGD guidelines has not mentioned regarding this.:confused:
Thank you,
Regards,
Dr. Kishan PV


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,662 registered users;
29 visitors (0 registered, 29 guests [including 6 identified bots]).
Forum time: 06:00 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5